Investing in today’s scientists for tomorrow’s breakthroughs
Our vision is a healthier world where all people have access to innovative,
life-changing medicines.
PhRMA Foundation Awards $1M for Equity-Focused Research on Digital Health Tools
The PhRMA Foundation awarded $500,000 grants to two researchers to conduct studies using digital health technologies to improve health equity and health outcomes for patients.
Research Areas
The PhRMA Foundation funds researchers working on the frontiers of variety of disciplines that impact patient health.
News
Read the latest news from the PhRMA Foundation blog.
Q&A with Carol Morris: Developing a Therapeutic for Faster Stroke Treatment
Q&A with Shrey Shah: Developing Microneedles to Treat Autoimmune Diseases
Application Advice From a Reviewer: Show You’re a Future Leader
Awardee Spotlight
Briana Simms, PhD
- University of Cincinnati
“This funding means that I get to design and develop a new generation of lipid nanomaterials alongside my friend and colleague, while empowering the next generation of stem scholars. It’s truly the best of all worlds.”
Grants & Fellowships
The PhRMA Foundation catalyzes the careers of promising researchers through competitive, peer-reviewed grants and fellowships.
Predoctoral Fellowships
PhRMA Foundation Predoctoral Fellowships provide up to two years in stipend support for full-time graduate students who are engaged in thesis research and have completed most of their pre-thesis requirements.
Postdoctoral Fellowships
PhRMA Foundation Postdoctoral Fellowships provide up to two years of stipend support to promising postdoctoral trainees who seek to further develop and refine their research skills.
Faculty Starter Grants
PhRMA Foundation Faculty Starter Grants provide support to promising young scientists beginning independent research careers at the faculty level.
Special Awards
The PhRMA Foundation periodically offers special funding opportunities to address specific research questions or topics of interest.
Supporters
The PhRMA Foundation owes its success to the pharmaceutical companies that have provided generous support over the past 60 years.
